Application of proteomics to hematology: The revolution is starting

Expert Review of Proteomics

Volumn 5, Issue 3, 2008, Pages 375-379

  Lion, Niels ^a,b   Tissot, Jean Daniel ^a  

^a Service Regional Vaudois de Transfusion Sanguine   (Switzerland)

^b EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROTEIN KINASE;

BLOOD ANALYSIS; BLOOD DISEASE; CLINICAL PRACTICE; EDITORIAL; ERYTHROCYTE; HUMAN; IMMUNOASSAY; IMMUNOCHEMISTRY; LYMPHOMA; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEOMICS; T LYMPHOCYTE; THROMBOCYTE FUNCTION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 45749133927     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/14789450.5.3.375     Document Type: Editorial

References (41)

1. Anderson L, Anderson NG. High resolution two-dimensional electrophoresis of human plasma proteins. Proc. Natl Acad. Sci. USA 74(12), 5421-5425 (1977).
2. Sennels L, Salek M, Lomas L, Boschetti E, Righetti PG, Rappsilber J. Proteomic analysis of human blood serum using peptide library beads. J. Proteome Res. 6(10), 4055-4062 (2007).
3. Omenn GS, States DJ, Adamski M et al. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 5(13), 3226-3245 (2005).
4. States DJ, Omenn GS, Blackwell TW et al. Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study. Nat. Biotechnol. 24(3), 333-338 (2006).
5. Low TY, Seow TK, Chung MCM. Separation of human erythrocyte membrane associated proteins with one-dimensional and two-dimensional gel electrophoresis followed by identification with matrix-assisted laser desorption/ionization- time of flight mass spectrometry. Proteomics 2(9), 1229-1239 (2002).
6. Kakhniashvili DG, Bulla LA Jr, Goodman SR. The human erythrocyte proteome: analysis by ion trap mass spectrometry. Mol. Cell. Proteomics 3(5), 501-509 (2004).
7. Pasini EM, Kirkegaard M, Mortensen P, Lutz HU, Thomas AW, Mann M. In-depth analysis of the membrane and cytosolic proteome of red blood cells. Blood 108(3), 791-801 (2006).
8. Marcus K, Immler D, Sternberger J, Meyer HE. Identification of platelet proteins separated by two-dimensional gel electrophoresis and analyzed by matrix assisted laser desorption/ionization-time of flight-mass spectrometry and detection of tyrosine-phosphorylated proteins. Electrophoresis 21(13), 2622-2636 (2000).
9. Coppinger JA, Cagney G, Toomey S et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 103(6), 2096-2104 (2004).
10. McRedmond JP, Park SD, Reilly DF et al. Integration of proteomics and genomics in platelets. A profile of platelet proteins and platelet-specific genes. Mol. Cell. Proteomics 3(2), 133-144 (2004).
11. Gevaert K, Goethals M, Martens L et al. Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides. Nat. Biotechnol. 21(5), 566-569 (2003).
12. Moebiust J, Zahedi RP, Lewandrowski U, Berger C, Walter U, Sickmann A. The human platelet membrane proteome reveals several new potential membrane proteins. Mol. Cell. Proteomics 4(11), 1754-1761 (2005).
13. Olivieri E, Herbert B, Righetti PG. The effect of protease inhibitors on the two-dimensional electrophoresis pattern of red blood cell membranes. Electrophoresis 22(3), 560-565 (2001).
14. Ayache S, Panelli M, Marincola FM, Stroncek DF. Effects of storage time and exogenous protease inhibitors on plasma protein levels. Am. J. Clin. Pathol. 126(2), 174-184 (2006).
15. Rai AJ, Gelfand CA, Haywood BC et al. HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics 5(13), 3262-3277 (2005).
16. Tammen H, Schulte I, Hess R, Menzel C, Kellmann M, Schulz-Knappe P. Prerequisites for peptidomic analysis of blood samples: I. Evaluation of blood specimen qualities and determination of technical performance characteristics. Comb. Chem. High Throughput Screen. 8(8), 725-733 (2005).
17. Hsieh SY, Chen RK, Pan YH, Lee HL. Systematical evaluation of the effects of sample collection procedures on low-molecular-weight serum/plasma proteome profiling. Proteomics 6(10), 3189-3198 (2006).
18. Davis MT, Auger P, Spahr C, Patterson SD. Cancer biomarker discovery via low molecular weight serum proteome profiling- where is the tumor? Proteomics Clin. Appl. 1(12), 1545-1558 (2007).
19. Davis MT, Patterson SD. Does the serum peptidome reveal hemostatic dysregulation? Ernst Schering Res. Found. Workshop (61), 23-44 (2007).
20. Miguet L, Pacaud K, Felden C et al. Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization. Proteomics 6(1), 153-171 (2006).
21. Sinauridze EI, Kireev DA, Popenko NY et al. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb. Haemost. 97(3), 425-434 (2007).
22. Morel O, Toti F, Hugel B et al. Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler. Thromb. Vasc. Biol. 26(12), 2594-2604 (2006).
23. Tammen H. Specimen collection and handling: standardization of blood sample collection. Methods Mol. Biol. 428, 35-42 (2007).
24. Zahedi RP, Lewandrowski U, Wiesner J et al. Phosphoproteome of resting human platelets. J. Proteome Res. 7(2), 526-534 (2008).
25. Lewandrowski U, Zahedi RP, Moebius J, Walter U, Sickmann A. Enhanced N-glycosylation site analysis of sialoglycopeptides by strong cation exchange prefractionation applied to platelet plasma membranes. Mol. Cell. Proteomics 6(11), 1933-1941 (2007).
26. Lewandrowski U, Moebius J, Walter U, Sickmann A. Elucidation of N-glycosylation sites on human platelet proteins: a glycoproteomic approach. Mol. Cell. Proteomics 5(2), 226-233 (2006).
27. Dittrich M, Birschmann I, Stuhlfelder C et al. Understanding platelets. Lessons from proteomics, genomics and promises from network analysis. Thromb. Haemost. 94(5), 916-925 (2005).
28. Goodman SR, Kurdia A, Ammann L, Kakhniashvili D, Daescu O. The human red blood cell proteome and interactome. Exp. Biol. Med. 232(11), 1391-1408 (2007).
29. Fujii K, Kondo T, Yamada M, Iwatsuki K, Hirohashi S. Toward a comprehensive quantitative proteome database: protein expression map of lymphoid neoplasms by 2-D DIGE and MS. Proteomics 6(17), 4856-4876 (2006).
30. Fujii K, Kondo T, Yokoo H et al. Protein expression pattern distinguishes different lymphoid neoplasms. Proteomics 5(16), 4274-4286 (2005).
31. Ma Y, Visser L, Roelofsen H et al. Proteomic analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes. Blood 111(4), 2339-2346 (2008).
32. Stoppini M, Mangione P, Monti M et al. Proteomics of β2-microglobulin amyloid fibrils. Biochim. Biophys. Acta 1753(1), 23-33 (2005).
33. Nepomuceno AI, Mason CJ, Muddiman DC, Bergen HR III, Zeldenrust SR. Detection of genetic variants of transthyretin by liquid chromatography-dual electrospray ionization Fourier-transform ion-cyclotron-resonance mass spectrometry. Clin. Chem. 50(9), 1535-1543 (2004).
34. Bergen HR III, Zeldenrust SR, Butz ML et al. Identification of transthyretin variants by sequential proteomic and genomic analysis. Clin. Chem. 50(9), 1544-1552 (2004).
35. Kaplan B, Ramirez-Alvarado M, Dispenzieri A et al. Isolation and biochemical characterization of plasma monoclonal free light chains in amyloidosis and multiple myeloma: a pilot study of intact and truncated forms of light chains and their charge properties. Clin. Chem. Lab. Med. 46(3), 335-341 (2008).
36. Tammen H, Mohring T, Kellmann M, Pich A, Kreipe HH, Hess R. Mass spectrometric phenotyping of Val34Leu polymorphism of blood coagulation factor XIII by differential peptide display. Clin. Chem. 50(3), 545-551 (2004).
37. Mann KG, Brummel-Ziedins K, Undas A, Butenas S. Does the genotype predict the phenotype? Evaluations of the hemostatic proteome. J. Thromb. Haemost. 2(10), 1727-1734 (2004).
38. Tissot JD, Vu DH, Aubert V et al. The immunoglobulinopathies: from physiopathology to diagnosis. Proteomics 2(7), 813-824 (2002).
39. Crettaz D, Sensebe L, Vu DH et al. Proteomics of methylene blue phototreated plasma before and after removal of the dye by an absorbent filter. Proteomics 4(3), 881-891 (2004).
40. Fortis F, Guerrier L, Areces LB et al. A new approach for the detection and identification of protein impurities using combinatorial solid phase ligand libraries. J. Proteome Res. 5(10), 2577-2585 (2006).
41. Thiele T, Steil L, Volker U, Greinacher A. Proteomics of blood-based therapeutics: a promising tool for quality assurance in transfusion medicine. BioDrugs 21(3), 179-193 (2007).